Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Hypoglycemia and glycemic variability of people with type 1 diabetes with lower and higher physical activity loads in free-living conditions using continuous subcutaneous insulin infusion with predictive low-glucose suspend system.
Montt-Blanchard D, Sánchez R, Dubois-Camacho K, Leppe J, Onetto MT. Montt-Blanchard D, et al. Among authors: onetto mt. BMJ Open Diabetes Res Care. 2023 Mar;11(2):e003082. doi: 10.1136/bmjdrc-2022-003082. BMJ Open Diabetes Res Care. 2023. PMID: 36944432 Free article.
Insulin settings and their association with time in range in patients with type 1 diabetes users of predictive low glucose suspend (PLGS) augmented insulin pumps in Santiago, Chile.
Grassi BA, Caramés B, Plaza-Plaza JC, Onetto MT, Moreno S, Sandoval T, Tapia N, Mena F, Revello A. Grassi BA, et al. Among authors: onetto mt. J Diabetes Complications. 2022 Aug;36(8):108262. doi: 10.1016/j.jdiacomp.2022.108262. Epub 2022 Jul 11. J Diabetes Complications. 2022. PMID: 35842304
Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile.
Grassi B, Onetto MT, Zapata Y, Jofré P, Echeverría G. Grassi B, et al. Among authors: onetto mt. Diabetes Metab Syndr. 2021 May-Jun;15(3):695-701. doi: 10.1016/j.dsx.2021.03.017. Epub 2021 Mar 23. Diabetes Metab Syndr. 2021. PMID: 33813244 Clinical Trial.